Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
British company’s shares up 35% this year as demand for health care information analysis grows Continue reading...
Anaqua, the leading provider of innovation and intellectual property management solutions, and Clarivate Plc (CCC), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced a strategic partnership that brings together two of the leading service providers in the trademark industry. The partnership will see CompuMark™, a part of Clarivate and industry leader in trademark research and protection solutions, working with Anaqua to help IP professionals work more efficiently. The alliance will provide seamless integration between the ANAQUA® IP Management platform and the CompuMark trademark research and protection platform, delivering significant workflow efficiencies for IP professionals.
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Clarivate Analytics plc (NYSE: CCC) ("Clarivate"), was scheduled to hold its 2020 Annual General Meeting of Shareholders ("AGM") at 2:00 p.m. BST on Thursday, May 7, 2020, at Hotel Sofitel London St. James, 6 Waterloo Place, St. James's, London SW1Y 4AN, United Kingdom. However, as a result of the ongoing COVID-19 coronavirus pandemic, UK authorities have issued stay-at-home orders that restrict public gatherings of more than two people. In order to do our part to assist in protecting the health and well-being of our shareholders and employees, Clarivate will adhere to all government and public health authority guidance to limit the spread of COVID-19. As a result, Clarivate has decided to make the following changes to the logistics for the AGM:
Baron Asset Fund recently published its first-quarter commentary – a copy of which can be downloaded here. During the first quarter of 2020, the Baron Asset Fund returned -16.63% (institutional shares). In comparison, the benchmark S&P 500 Index was down 19.60%, while the Russell Midcap Growth Index was down 20.04%. In the said letter, Baron Asset […]
Clarivate Analytics plc (NYSE:CCC; CCC.WS) ("Clarivate"), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced it has completed its acquisition of Decision Resources Group ("DRG"). Previously, Clarivate announced on January 17, 2020 its intent to acquire DRG from Piramal Enterprises Limited ("PEL", NSE: PEL, BSE: 500302), part of global business conglomerate Piramal Group.
Clarivate Analytics plc (NYSE:CCC) (the "Company"), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that its Board of Directors has nominated Jane Okun Bomba and Richard W. Roedel to stand for election as directors at its 2020 Annual General meeting of stockholders on May 7 (the "Annual General Meeting"). Sir Martin Broughton, Charles E. Moran and Amir Motamedi have served as Class I directors since May 2019 and are not standing for election at the Annual General Meeting. In addition, Matthew Scattarella, who has served as a Class II director since May 2019, will step down from the Board effective as of the date of the Annual General Meeting.
Healthcare Business Insights (HBI), a part of Clarivate Analytics Plc (NYSE: CCC), announced the 2019 winners of its annual Revenue Cycle Awards. In its eighth year, the Revenue Cycle Awards recognize healthcare organizations for their outstanding performance on revenue cycle KPIs, based on data from their most recent, and preceding, full fiscal year. The 2019 Revenue Cycle Awards recipients include Liberty Hospital - MO, Nebraska Medicine - NE, Novant Health - NC and The Valley Hospital - NJ.
LONDON and PHILADELPHIA , April 22, 2020 /CNW/ -- Clarivate Analytics (CCC) today announced the addition of open access data to the Journal Citation Reports profile pages to increase transparency around open access models in scholarly publishing. The Journal Citation Reports is an annual journal report from the Web of Science, the world's largest publisher-independent global citation database. This provides the research community with transparent, publisher-neutral information about the relative contribution of articles published free to read and re-use under Creative Commons licenses ('gold open access') to a journal's overall volume of content and citations.
Clarivate Analytics Plc (NYSE: CCC) (the "Company" or "Clarivate"), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today reported results for the first quarter ended March 31, 2020.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Clarivate Analytics Plc (CCC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clarivate Analytics Plc (NYSE:CCC) a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Cortellis Clinical Trials Intelligence™ has been enhanced with new site selection analytics. Cortellis Clinical Trials Intelligence is a powerful and user-friendly resource to plan clinical trials, helping to accelerate clinical trial development decisions, select trial sites, inform portfolio strategy and provide key competitive intelligence.
Clarivate Analytics Plc's (NYSE:CCC): Clarivate Analytics Plc, an information services and analytics company, provides...
Clarivate Analytics Plc (CCC) delivered earnings and revenue surprises of -12.50% and -1.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Clarivate Analytics, the IBD Stock of the Day, is a provider of services and data analytics used for scientific research, intellectual property and life sciences that accelerate innovation.
LONDON , March 9, 2020 /CNW/ -- The Centre for Innovation in Regulatory Science (CIRS), a neutral and independent, international member-based organisation headquartered in the UK, has been awarded a phase two grant of $1.09m by the Bill & Melinda Gates Foundation to continue their collaborative endeavours to expedite patient access to medicines in specific areas of greatest medical need in Low and Middle Income Countries (LMICs)*1. The grant has been awarded to CIRS for the purpose of 'Tracking Regulatory Performance Metrics in Low and Middle Income Countries' to accelerate and consolidate the activities around a unique metrics collection programme which aims to assist LMICs achieve targeted improvements in regulatory performance goals and ultimately, to accelerate registration of quality medicines in these countries.
LONDON and PHILADELPHIA , April 22, 2020 /CNW/ -- Clarivate Analytics Plc (CCC), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has today released a new report unveiling the bioplastics1 innovation landscape. Download the full report entitled 'From the Plastics Present to a Sustainable Future'. With growing consumer, governmental and organizational awareness of the need to radically change our approach to plastic usage and disposal, bioplastic has emerged as one of the potential solutions to a more sustainable future.
Clarivate Analytics plc (NYSE: CCC) (the "Company"), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced it will report its financial results for the first quarter 2020 before the market opens on Monday, May 4. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at www.clarivate.com. The Company will host a conference call and webcast on Monday, May 4 at 8:00 AM Eastern Time to review the results.